AVROBIO (NASDAQ:AVRO – Get Free Report) and Clarus Therapeutics (OTCMKTS:CRXTQ – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability. Institutional & Insider Ownership 60.0% of AVROBIO shares […]